Adam Feuerstein slams NWBO and its CEO Linda Powers. Has an open mind re IMUC.
Adam Feuerstein completely discredits NWBO, the company, the CEO and its Phase I and Phase II clinical trial results. He claims that CEO Linda Powers has a checkered past and spends more time promoting its drug than actually developing a meaningful drug to combat GBM.
He reiterates that he has an open mind regarding end of year results from the first legitimate, adequately designed trial to test ICT-107. After reading his article I conclude there is really only one contender that has a legitimate shot at combating the terrrible disease, GBM. IMUC is in the driver's seat and our future looks great. GLTA.
Let's not forget his bash article on IMUC last spring or summer that sent our stockdown 20% to 30%. I questiion his whole agenda no matter who or what he has to say. His open mind depends on where the bets are placed I think.
Good point. However, Adam does appear to have an open mind regarding our Phase III results. He notes that our trial is adequately designed and should be taken seriously.
Also, I think it is interesting that his recent February 8, 2013 article on IMUC stated that he thinks the interim analysis by the DMC will probably boost our pps by a buck or two, even though he does not perceive the DMC analysis to be particulary important.
Hey, I think a two buck boost is very relevant. I like it.